HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Beibei Li Selected Research

human ERBB2 protein

4/2022Overexpression of lncRNA MAPT-AS1 exacerbates cell proliferation and metastasis in breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Beibei Li Research Topics

Disease

31Infections
04/2024 - 01/2013
21Neoplasms (Cancer)
03/2024 - 01/2011
9Virus Diseases (Viral Diseases)
01/2022 - 01/2013
6Inflammation (Inflammations)
11/2023 - 01/2016
5Bacterial Infections (Bacterial Infection)
04/2024 - 01/2017
4Neoplasm Metastasis (Metastasis)
04/2022 - 11/2012
3Chronic Obstructive Pulmonary Disease (COPD)
11/2023 - 07/2021
3Breast Neoplasms (Breast Cancer)
04/2022 - 01/2011
3Atherosclerosis
10/2020 - 04/2009
2Ovarian Neoplasms (Ovarian Cancer)
03/2024 - 05/2022
2Fibrosis (Cirrhosis)
02/2024 - 01/2016
2Adenocarcinoma of Lung
11/2023 - 01/2019
2Airway Remodeling
11/2023 - 07/2021
2Disease Resistance
04/2022 - 01/2019
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2019 - 01/2019
2Japanese Encephalitis
01/2019 - 01/2014
2Carcinoma (Carcinomatosis)
01/2019 - 11/2012
2Paralysis (Palsy)
07/2018 - 08/2017
2Testicular Neoplasms (Testicular Cancer)
02/2018 - 12/2015
1Viremia
04/2024
1Osteoporosis
04/2024
1Atrophy
02/2024
1Hemorrhage
02/2024
1Edema (Dropsy)
02/2024
1Dysbiosis
01/2024
1T-Cell Lymphoma (Lymphoma, T Cell)
01/2024
1Carcinogenesis
11/2023
1Adenocarcinoma
11/2023
1Human Influenza (Influenza)
11/2023
1Communicable Diseases (Infectious Diseases)
11/2023
1COVID-19
11/2023
1Dandruff
09/2023
1Polyps
04/2023
1Fever (Fevers)
01/2023
1Acalculous Cholecystitis
01/2023
1Cholecystitis
01/2023

Drug/Important Bio-Agent (IBA)

10Antiviral Agents (Antivirals)IBA
01/2023 - 08/2015
8Peptides (Polypeptides)IBA
04/2022 - 11/2015
7Proteins (Proteins, Gene)FDA Link
01/2024 - 01/2013
5MicroRNAs (MicroRNA)IBA
11/2023 - 01/2017
5Peptide Hydrolases (Proteases)FDA Link
11/2023 - 01/2021
5InterferonsIBA
10/2020 - 01/2013
4Immune Checkpoint InhibitorsIBA
03/2024 - 01/2023
4Long Noncoding RNAIBA
11/2023 - 01/2019
3Antimicrobial PeptidesIBA
04/2024 - 02/2021
3Circular RNAIBA
11/2023 - 01/2023
3RNA (Ribonucleic Acid)IBA
11/2023 - 08/2017
3Messenger RNA (mRNA)IBA
11/2023 - 01/2020
3VaccinesIBA
01/2022 - 01/2019
2swine leukocyte antigenIBA
04/2024 - 01/2017
2CytokininsIBA
01/2024 - 01/2021
2CateninsIBA
11/2023 - 04/2022
2Competitive Endogenous RNAIBA
01/2023 - 01/2023
2Interleukin-6 (Interleukin 6)IBA
01/2023 - 04/2009
2Biomarkers (Surrogate Marker)IBA
05/2022 - 01/2021
2AntibodiesIBA
01/2022 - 01/2022
2CollagenIBA
07/2021 - 01/2021
2DefensinsIBA
02/2021 - 10/2020
2Poly I-CIBA
10/2020 - 01/2020
2Apolipoproteins E (ApoE)IBA
10/2020 - 04/2016
2Transcription Factors (Transcription Factor)IBA
01/2020 - 08/2015
2LigandsIBA
01/2020 - 05/2017
2CytokinesIBA
01/2020 - 08/2015
2APTIBA
11/2019 - 01/2019
2AmidesIBA
11/2019 - 01/2019
2Protons (Proton)IBA
11/2019 - 01/2019
2ChemokinesIBA
10/2018 - 08/2015
2Cisplatin (Platino)FDA LinkGeneric
02/2018 - 12/2015
2IntegrinsIBA
01/2018 - 11/2012
2MicellesIBA
05/2017 - 11/2015
2Prolyl Hydroxylases (Prolyl Hydroxylase)IBA
04/2016 - 03/2015
2Reactive Oxygen Species (Oxygen Radicals)IBA
01/2016 - 06/2014
2Interferon Type IIBA
11/2014 - 06/2013
2Carrier Proteins (Binding Protein)IBA
11/2014 - 01/2013
1Arginine (L-Arginine)FDA Link
04/2024
1Tryptophan (L-Tryptophan)FDA Link
04/2024
1nasIBA
04/2024
1AlkaloidsIBA
04/2024
1AcidsIBA
04/2024
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
03/2024
1GhrelinIBA
02/2024
1Hemin (Panhematin)FDA Link
02/2024
1GlycosidesIBA
01/2024
1Histones (Histone)IBA
01/2024
1baicalinIBA
01/2024
1Sirtuin 2IBA
01/2024
1A-factor (Streptomyces)IBA
01/2024
1LipidsIBA
11/2023
1Lipid Bilayers (Lipid Bilayer)IBA
11/2023
1oxybutynin (Tavor)FDA LinkGeneric
11/2023
1Protease Inhibitors (Protease Inhibitor)IBA
11/2023
1fludioxonilIBA
09/2023
1MineralsIBA
04/2023
1PolyphosphatesIBA
04/2023

Therapy/Procedure

5Therapeutics
04/2024 - 05/2017
5Drug Therapy (Chemotherapy)
01/2022 - 01/2011
4Immunotherapy
03/2024 - 01/2023
1Radiotherapy
03/2024
1Length of Stay
01/2023
1Cholecystostomy
01/2023